Saratoga Health & Biotechnology Fund's Saratoga Health & Biotechnology Fund (SBHIX) has disclosed 32 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2024-02-29. The current portfolio value is calculated to be $12.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 7%.
Saratoga Health & Biotechnology Fund (SBHIX)'s
Total Assets is $12.13 Mil , Total Liabilities is $41,710.00 , Net Assets is $12.09 Mil.
In Saratoga Health & Biotechnology Fund (SBHIX)'s current portfolio as of 2024-02-29, the top 5 holdings are
Regeneron Pharmaceuticals Inc (REGN), Cencora Inc (COR), McKesson Corp (MCK), Amgen Inc (AMGN) and The Cigna Group (CI),
not including call and put options.
Saratoga Health & Biotechnology Fund (SBHIX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for Saratoga Health & Biotechnology Fund (SBHIX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for Saratoga Health & Biotechnology Fund (SBHIX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Saratoga Health & Biotechnology Fund.